InSilicoTrials and IBSA Join Forces to Innovate Clinical Trials with Advanced Computer Modeling

MILAN, May 25, 2023 /PRNewswire/ — InSilicoTrials – a leading provider of artificial intelligence and simulation tools for drug and medical device development, and IBSA Group – one of the major players worldwide in the fields of Reproductive Medicine and hyaluronic acid-based products, have…

Source: www.prnewswire.com – Read more